About this trial
The purpose of this project is to explore the effects of transcranial alternating current stimulation (tACS) in children, adolescents and young adults with a 22q11.2 microdeletion. The main aim of the present research project is to investigate the effects of repeated, individually tuned high-density (HD) tACS on cognition (i.e., WM performance) and related neuroimaging markers in carriers of the 22q11DS. As cognitive deficits, most notably WM impairment, are among the earliest signs of psychotic disorders, interventions during adolescence aimed at reducing cognitive decline in at-risk individuals may prove effective in delaying or even preventing the later emergence of psychotic symptoms.
Eligibility criteria
Qualifiers
Confirmed genetic diagnosis of 22q11DS
Age between 14 and 25 years old
Willingness to participate
Informed Consent signed by the subject and/or the caregiver(s)
Disqualifiers
Epilepsy
Deep brain stimulation electrodes
Traumatic brain injury
Facial metal implants
Trial design
Treatments tested in this trial
- at-home tACS using Starstim-Home tES
Treatment groups
Sponsors and collaborators
Stephan Eliez
Lead sponsor
University of Geneva, Switzerland
Sponsor institution